Home LiteratureArticle Details
PMID: 2662193 Published · ppublish English Journal Article

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization.

Beissert S, Bergholz M, Waase I, Lepsien G, Schauer A, Pfizenmaier K, Krönke M

Abstract

Tumor necrosis factor (TNF) produced by macrophages is thought to contribute to the host defense against development of cancer. However, since tumor cells themselves are able to produce TNF, it is conceivable that TNF may also play an adverse pathological role in carcinogenesis. To better understand the functional significance of TNF in neoplastic disease, we have determined the cellular source of TNF activity produced in 10 patients with colorectal cancer. Northern blot analysis of RNAs extracted from fresh biopsy specimens revealed detectable TNF mRNA levels in all instances. By using in situ hybridization of frozen sections, scattered cells expressing TNF mRNA could be discerned. Based on morphological criteria, these TNF-positive cells most likely belong to the macrophage lineage. Macrophages in normal tissue surrounding the tumor did not express TNF mRNA, suggesting that macrophage activation occurs locally at the site of neoplastic transformation. Immunohistochemistry using anti-TNF monoclonal antibodies revealed that less than 1% of tumor-infiltrating macrophages synthesize TNF protein. Thus we present evidence that in colorectal cancer only a small proportion of tumor-infiltrating macrophages produces TNF, indicating that the microenvironment of the tumor provides adequate, yet suboptimal, conditions for macrophage activation.

MeSH Terms
Adenocarcinoma/genetics,pathology Antibodies, Monoclonal Biopsy Colorectal Neoplasms/genetics,pathology Gene Expression Regulation Genes Humans Immunoenzyme Techniques Macrophages/metabolism,pathology Nucleic Acid Hybridization RNA Probes RNA, Messenger/analysis,genetics Tumor Necrosis Factor-alpha/genetics
Chemicals
Antibodies, Monoclonal RNA Probes RNA, Messenger Tumor Necrosis Factor-alpha
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Beissert S
Klinische Arbeitsgruppe, Max-Planck-Gesellschaft, Göttingen, Federal Republic of Germany.
Bergholz M
Waase I
Lepsien G
Schauer A
Pfizenmaier K
Krönke M
References (30)
30 references, click to expand
  1. An endotoxin-induced serum factor that causes necrosis of tumors.
    Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 PMID: 1103152
  2. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    J Immunol. 1988 Sep 15;141(6):2006-15 PMID: 3139748
  3. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    J Immunol. 1978 Nov;121(5):2035-42 PMID: 712076
  4. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
  5. Initial characterization of monoclonal antibodies against human monocytes.
    Proc Natl Acad Sci U S A. 1980 Nov;77(11):6764-8 PMID: 6935683
  6. Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer.
    Proc Natl Acad Sci U S A. 1981 Jan;78(1):616-20 PMID: 6165999
  7. Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.
    Proc Natl Acad Sci U S A. 1983 Oct;80(20):6341-5 PMID: 6604918
  8. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).
    J Histochem Cytochem. 1984 Feb;32(2):219-29 PMID: 6198355
  9. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):724-9 PMID: 6392892
  10. Tumor necrosis factor (TNF).
    Science. 1985 Nov 8;230(4726):630-2 PMID: 2413547
  11. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
    J Exp Med. 1985 Dec 1;162(6):2163-8 PMID: 2999289
  12. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.
    Nature. 1985 Dec 19-1986 Jan 1;318(6047):665-7 PMID: 3001529
  13. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Nature. 1986 Apr 17-23;320(6063):584-8 PMID: 3010124
  14. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.
    Science. 1986 May 23;232(4753):977-80 PMID: 3754653
  15. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5233-7 PMID: 3487788
  16. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.
    J Exp Med. 1986 Oct 1;164(4):1350-5 PMID: 3020152
  17. Secretory products of macrophages.
    J Clin Invest. 1987 Feb;79(2):319-26 PMID: 3543052
  18. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
    Lab Invest. 1987 Mar;56(3):234-48 PMID: 3029503
  19. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.
    J Exp Med. 1987 Jun 1;165(6):1581-94 PMID: 3108447
  20. Autocrine stimulation of TNF-alpha mRNA expression in HL-60 cells.
    Lymphokine Res. 1987 Spring;6(2):119-25 PMID: 3108589
  21. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo.
    Proc Natl Acad Sci U S A. 1987 Aug;84(15):5277-81 PMID: 2440047
  22. Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells.
    N Engl J Med. 1987 Aug 27;317(9):526-32 PMID: 3497347
  23. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.
    Proc Natl Acad Sci U S A. 1987 Sep;84(18):6563-6 PMID: 3476961
  24. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.
    Nature. 1987 Oct 15-21;329(6140):630-2 PMID: 2443857
  25. Evidence for tumour necrosis factor/cachectin production in cancer.
    Lancet. 1987 Nov 28;2(8570):1229-32 PMID: 2890853
  26. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.
    Cell. 1988 Apr 8;53(1):45-53 PMID: 3349526
  27. Lymphotoxin.
    Annu Rev Immunol. 1988;6:407-38 PMID: 3289572
  28. IL-2 production in human T lymphotropic virus I-infected leukemic T lymphocytes analyzed by in situ hybridization.
    J Immunol. 1988 Aug 15;141(4):1231-5 PMID: 2899602
  29. Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines.
    Cancer Res. 1988 Oct 1;48(19):5417-21 PMID: 3262009
  30. Macrophage tumor killing: influence of the local environment.
    Science. 1977 Jul 15;197(4300):279-82 PMID: 327547
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1989-07-00
Pages
5064-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC297557
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com